| Literature DB >> 32513273 |
Limin Wang1, Hongbo Chen1, Han Lu1, Yunlin Wang1, Congying Liu2, Xu Dong1, Jieru Chen1, Nan Liu3, Fang Yu4, Qiaoqin Wan1, Shaomei Shang5.
Abstract
BACKGROUND: Knee osteoarthritis (KOA) is a common joint disease in people over 60 years old. Exercise therapy is one of the most effective non-pharmacological treatments for KOA, but low exercise adherence needs to be improved. The present study aimed to evaluate the effect of the transtheoretical model-lead home exercise intervention (TTM-HEI) program on exercise adherence, KOA symptoms, and knee function in older adults with KOA.Entities:
Keywords: Exercise adherence; Intervention; Knee function; Knee osteoarthritis; Latent growth model; Symptom
Mesh:
Year: 2020 PMID: 32513273 PMCID: PMC7278156 DOI: 10.1186/s13075-020-02222-y
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Fig. 1Flowchart of the study participants
The demographic characteristics of the recruited participants at baseline
| Characteristic | Intervention ( | Control ( | |||
|---|---|---|---|---|---|
| (%) | (%) | ||||
| Age—mean (SD), years‡ | 67.38 | (7.79) | 68.81 | (6.74) | 0.182 |
| Gender† | |||||
| Male | 10 | (9.7) | 4 | (4.7) | 0.266 |
| Female | 93 | (90.3) | 82 | (95.3) | |
| Body mass index—mean (SD), kg/m2‡ | 25.12 | (3.58) | 24.85 | (3.05) | 0.578 |
| Symptom duration—mean (SD), years‡ | 7.54 | (7.83) | 7.08 | (7.27) | 0.680 |
| Level of education† | 0.215 | ||||
| Primary school or less | 3 | (2.9) | 5 | (5.8) | |
| Junior high school | 26 | (25.2) | 29 | (33.7) | |
| High school | 39 | (37.9) | 33 | (38.4) | |
| College graduate and above | 35 | (34.0) | 19 | (22.1) | |
| Marital status† | 0.445 | ||||
| Single | 16 | (15.5) | 17 | (19.8) | |
| Married | 87 | (84.5) | 69 | (80.2) | |
| Number of affected knees† | 0.259 | ||||
| One | 54 | (52.4) | 38 | (44.2) | |
| Two | 49 | (47.6) | 48 | (55.8) | |
| Uses a walker† | 0.997 | ||||
| Yes | 6 | (5.8) | 5 | (5.8) | |
| No | 97 | (94.2) | 81 | (94.2) | |
| Comorbid conditions† | |||||
| Hypertension | 0.077 | ||||
| Yes | 44 | (42.7) | 26 | (30.2) | |
| No | 59 | (57.3) | 60 | (69.8) | |
| Diabetes | 0.015* | ||||
| Yes | 18 | (17.5) | 5 | (5.8) | |
| No | 85 | (82.5) | 81 | (94.2) | |
| Coronary heart disease | 0.085 | ||||
| Yes | 12 | (11.7) | 4 | (4.7) | |
| No | 91 | (88.4) | 82 | (95.4) | |
| Osteoporosis | 0.578 | ||||
| Yes | 32 | (31.1) | 30 | (34.9) | |
| No | 71 | (68.9) | 56 | (65.1) | |
| Current drug use† | |||||
| Analgesics | 0.669 | ||||
| Yes | 10 | (9.7) | 10 | (11.6) | |
| No | 93 | (90.3) | 76 | (88.4) | |
| Cartilage protection drugs | 0.937 | ||||
| Yes | 16 | (15.5) | 13 | (15.1) | |
| No | 87 | (84.5) | 73 | (84.9) | |
SD standard deviation
†Chi-square or Fisher’s exact tests were used
‡Independent samples t test was used
*p < 0.05 was considered statistically significant
Exercise adherence score over time by group
| Intervention ( | Control ( | |||
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | |||
| Week 4 | 7.59 ± 1.64 | 7.47 ± 2.24 | 0.450 | 0.653 |
| Week 12 | 6.27 ± 1.86 | 6.19 ± 2.28 | 0.254 | 0.800 |
| Week 24 | 7.58 ± 1.29 | 5.00 ± 1.53 | 11.646 | < 0.001# |
| Week 36 | 6.55 ± 1.28 | 3.89 ± 1.53 | 12.043 | < 0.001# |
| Week 48 | 5.56 ± 1.00 | 3.16 ± 1.31 | 12.999 | < 0.001# |
| 65.971 | 53.664 | |||
| < 0.001* | < 0.001* |
Exercise adherence was evaluated by the participants filling in the NRS (0 = not at all through 10 = completely as instructed)
SD standard deviation
†Independent t test was used
‡One-way repeated measurement ANOVA was used
*p < 0.05 was considered statistically significant
#p < α’ = 0.05/5 = 0.01 was considered statistically significant
Fig. 2Exercise adherence scores in the intervention and control groups over 48 weeks
Fig. 3Main estimated parameter diagrams using the three models. a Model 1: conducting group as a covariate (0: control group, 1: intervention group). b Model 2: control group. c Model 3: intervention group. The path loading of the intercept is shown by bold italic font, and the path loadings of the slope are shown by regular front. ***p < 0.001, **p < 0.01, *p < 0.05
Secondary outcome measures over time in the control and intervention groups
| Intervention ( | Control ( | |||
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | |||
| Pain intensity# | ||||
| Baseline | 24.37 ± 20.31 | 24.42 ± 19.65 | − 0.017 | 0.986 |
| Week 24 | 16.18 ± 15.94 | 23.47 ± 17.11 | − 2.793 | 0.006# |
| Week 48 | 13.62 ± 11.28 | 19.64 ± 16.83 | − 2.550 | 0.012# |
| 7.072 | 2.085 | |||
| 0.001* | 0.131 | |||
| Joint stiffness# | ||||
| Baseline | 24.03 ± 24.73 | 25.00 ± 25.37 | − 0.266 | 0.791 |
| Week 24 | 10.53 ± 12.49 | 19.62 ± 19.88 | − 3.376 | 0.001# |
| Week 48 | 9.77 ± 14.19 | 17.57 ± 21.36 | − 2.611 | 0.010# |
| 13.374 | 0.945 | |||
| < 0.001* | 0.394 | |||
| Lower limb muscle strength | ||||
| Baseline | 12.03 ± 5.09 | 12.27 ± 4.29 | − 0.350 | 0.727 |
| Week 24 | 9.61 ± 2.43 | 11.34 ± 3.66 | − 3.583 | < 0.001# |
| Week 48 | 10.29 ± 3.70 | 11.06 ± 2.79 | − 1.442 | 0.151 |
| 19.441 | 3.565 | |||
| < 0.001* | 0.034* | |||
| Balance | ||||
| Baseline | 2.95 ± 0.29 | 2.03 ± 0.22 | − 0.775 | 0.439 |
| Week 24 | 1.26 ± 0.13 | 1.60 ± 0.19 | − 4.747 | < 0.001# |
| Week 48 | 1.11 ± 0.12 | 1.22 ± 0.15 | − 2.576 | 0.011# |
| 13.847 | 6.687 | |||
| < 0.001* | 0.002* | |||
SD standard deviation
†Independent t test was used
‡One-way repeated measurement ANOVA was used
*p < 0.05 was considered statistically significant
#The score range for pain intensity and joint stiffness is 0–100; p < α’ = 0.05/3 ≈ 0.017 was considered statistically significant